Meeting
2022 ASCO Quality Care Symposium
Real-world uptake and concordance of actionable genetic mutations between tissue NGS and liquid biopsy in oncology patients in a safety-net hospital: A single center analysis.
Authors
Steven Badami
University of Florida Health, Jacksonville, FL
Steven Badami, Kimberly Boldig, Abhinav Rohatgi
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B
Track
Palliative and Supportive Care,Technology and Innovation in Quality of Care,Quality, Safety, and Implementation Science
Sub Track
Tools for Management of Treatment and Adverse Effects
Citation
J Clin Oncol 40, 2022 (suppl 28; abstr 426)
DOI
10.1200/JCO.2022.40.28_suppl.426
Abstract #
426
Poster Bd #
F29
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Association of longitudinal changes of genomic alteration of circulating tumor DNA with treatment response in pancreatic cancer.
First Author: Jin Ho Choi
Poster
2023 ASCO Breakthrough
CRISPincette, and detection of low frequency cancer mutations in ctDNA.
First Author: Jin-Soo Kim
Poster
2019 Breakthrough
An optimized ultra-deep massively parallel sequencing with unique molecular identifier tagging for detection and quantification of circulating tumor DNA from lung cancer patients.
First Author: Hong-Anh Thi Pham
Poster
2018 ASCO Annual Meeting
Real world results of liquid biopsy in stage 3/4 solid tumors and potential ''clinical actionability."
First Author: Rebecca Christian Arend